Century Therapeutics (IPSC) Preferred Shares (2020)
Century Therapeutics (IPSC) reported Preferred Shares of $144.8 million for Q4 2020.
Century Therapeutics (IPSC) has 1 years of Preferred Shares data on file, last reported at $144.8 million in Q4 2020.
- Quarterly Preferred Shares changed N/A year-over-year to $144.8 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $144.8 million (changed N/A YoY) and the FY2020 annual result came in at $144.8 million, changed N/A from the prior year.
- Preferred Shares steadied at $144.8 million in Q4 2020 per IPSC's latest filing.
- Across five years, Preferred Shares topped out at $144.8 million in Q4 2020 and bottomed at $144.8 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Century Therapeutics | 474.01 Mn | 474.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 144.84 Mn |